The host focuses on good news related to the coronavirus, starting with clinical trials for a vaccine in Seattle. They highlight the participation of volunteers and the role of private sector innovation.
Phase 1 clinical trials for a coronavirus vaccine started in Seattle.
At least four people participated in the trial.
The vaccine is mRNA-1273, developed by Moderna and the NIH.
The trial aims to test three different doses of the vaccine in 45 healthy adults.